Merck & Co., Inc. (MRK) Tops Q3 EPS by 3c

October 26, 2012 7:01 AM EDT
Merck & Co., Inc. (NYSE: MRK) reported Q3 EPS of $0.95, $0.03 better than the analyst estimate of $0.92. Revenue for the quarter came in at $11.5 billion versus the consensus estimate of $11.6 billion.

Merck & Co., Inc. sees FY2012 EPS of $3.78-3.82, versus prior guidance of $3.75-3.85 and the consensus of $3.81.

For earnings history and earnings-related data on Merck & Co., Inc. (MRK) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance, Hot Earnings

Related Entities